Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × rofecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteoarthritis 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cancer Pain 1 Brain Stem Neoplasms 1 Brain Neoplasms 1 Barrett Esophagus 1 Advanced Non-small Cell Lung Cancer 1 Adenomatous Polyposis Coli 1

Interventions

Endoscopy 15 Endoscopy, Digestive System 12 Biopsy 9 Endoscopic Mucosal Resection 8 Radiofrequency Ablation 7 Esomeprazole 7 Specimen Handling 6 Gastroscopy 6 Omeprazole 4 Aspirin 4 Proflavine 3 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 omeprazole, sodium bicarbonate drug combination 1 obeticholic acid 1 gluconic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637988 2011-01-21

Barrett's Esophagus - 315 - 3 Way Cross Over

AstraZeneca

Phase 4 Completed

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡